This off-the radar company and has the potential to be a huge winner with the administration and Congress signaling possible marijuana legalization. Akerna Corp. (NASDAQ: KERN) offers the MJ Platform, an enterprise resource planning system to the cannabis industry, and Leaf Data Systems, a tracking system designed for government agencies.
The company also provides consulting services to the cannabis industry. Its business intelligence infrastructure as a service tool delivers supply chain analytics for the cannabis, hemp and CBD industries. Last Call Analytics is a subscription analytics tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates a seed-to-sale platform that allows cultivators to track and report various stages of their cannabis growing operations, production and sales processes.
Akerna also offers cannabis cultivation management and software to manage and optimize operational workflow in business analytics, as well as cannabis tracking technology that provides seed-to-sale-to-self data.
Lake Street recently started coverage and has an $8 target price. The consensus target for Akerna stock is $8, and the shares traded at $3.30 on Friday.
This off-the-radar stock offers aggressive investors big upside potential. Aurora Mobile Ltd. (NYSE: JG) engages in the provision of mobile big data solutions platforms. It also offers mobile apps and provides core in-app functionalities needed by developers, including push notification, instant messaging, analytics and sharing and short message service.
The company also provides application programming interfaces that create connectivity and automate the process of message exchange between the mobile apps and its backend network. Its interactive web-based service dashboard allows app developers to utilize and monitor its services through controls on an ongoing basis. It primarily serves mobile app developers in a range of industries, such as media, entertainment, gaming, financial services, tourism, e-commerce, education and health care.
Oppenheimer’s $4 price target is greater than the $3.04 consensus target. On Friday, the stock traded at $2.00 per share.